Previous Article | Next Article 
Mol Cell Biol, February 1998, p. 703-709, Vol. 18, No. 2
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Differential Expression of Individual Suppressor
tRNATrp Gene Family Members In Vitro and In Vivo in the
Nematode Caenorhabditis elegans
Ling
Li,1
Rob M.
Linning,1
Kazunori
Kondo,2 and
Barry M.
Honda1,*
Institute of Molecular Biology and
Biochemistry and Department of Biological Sciences, Simon Fraser
University, Burnaby, British Columbia V5A 1S6,
Canada,1 and
Department of
Bioengineering, Soka University, Hachioji, Tokyo 192, Japan2
Received 22 July 1997/Returned for modification 4 September
1997/Accepted 18 November 1997
 |
ABSTRACT |
Eight different amber suppressor tRNA (suptRNA) mutations in the
nematode Caenorhabditis elegans have been isolated; all are derived from members of the tRNATrp gene family (K. Kondo,
B. Makovec, R. H. Waterston, and J. Hodgkin, J. Mol. Biol.
215:7-19, 1990). Genetic assays of suppressor activity suggested that
individual tRNA genes were differentially expressed, probably in a
tissue- or developmental stage-specific manner. We have now examined
the expression of representative members of this gene family both in
vitro, using transcription in embryonic cell extracts, and in vivo, by
assaying suppression of an amber-mutated lacZ reporter gene
in animals carrying different suptRNA mutations. Individual wild-type
tRNATrp genes and their amber-suppressing counterparts
appear to be transcribed and processed identically in vitro, suggesting
that the behavior of suptRNAs should reflect wild-type tRNA expression.
The levels of transcription of different suptRNA genes closely parallel
the extent of genetic suppression in vivo. The results suggest that differential expression of tRNA genes is most likely at the
transcriptional rather than the posttranscriptional level and that 5'
flanking sequences play a role in vitro, and probably in vivo as well. Using suppression of a lacZ(Am) reporter gene as a more
direct assay of suptRNA activity in individual cell types, we have
again observed differential expression which correlates with genetic and in vitro transcription results. This provides a model system to
more extensively study the basis for differential expression of this
tRNA gene family.
 |
INTRODUCTION |
The classical picture of eukaryotic
tRNA gene transcription has two factors, TFIIIB and TFIIIC, interacting
with internal promoter sequences and allowing transcription initiation
by RNA polymerase III; more recent studies, however, indicate a more complex and interesting picture (see reference 36
for a recent, comprehensive review). Typically, each tRNA is encoded by
multiple members of a gene family with similar or identical tRNA coding sequences but often differences in flanking sequences. Numerous studies
with isolated tRNA genes and cell extracts clearly demonstrate that
flanking sequences can strongly influence the level of transcription in
vitro either positively or negatively (12, 16, 27, 32, 35, 36, 43,
45), and there are now several examples of regulated or
differential expression of tRNA genes (reviewed in reference
36). Examples of such regulation include the silk gland-specific expression of a set of novel tRNAAla genes
in the silkworm Bombyx mori (37) and in spiders
(2), as well as differential transcription of
tRNAGly species in B. mori (11); an
oocyte-specific tRNATyr in Xenopus laevis
(39); changes in tRNA expression in response to viral
infection or cell cycle events (reviewed in reference 36); developmental differences for tRNA genes with
distinctive primary transcripts in Dictyostelium discoideum
(5) and Drosophila melanogaster (40);
and evidence based upon genetic studies with amber suppressor mutations
in tRNATrp genes in the nematode Caenorhabditis
elegans (19, 20).
In terms of mechanisms for differential regulation of tRNA gene
expression, work with B. mori has shown that 5' flanking
sequences determine tissue specificity for silk gland versus
constitutive tRNAAla genes (47), with
differences in TFIIIB interactions a major factor in determining
differences in expression levels (46). Flanking sequences
have also been implicated in the differential expression of
oocyte-specific tRNATyr genes of X. laevis
(29, 39). It has been possible to study the expression and
regulation of individual tRNA genes in yeast (see, for example,
references 17, 28, and
34; reviewed in references 16 and
43) and of suppressing tRNA (suptRNA) or otherwise
marked tRNA genes in cultured cells (13, 41). However, it
has been difficult to study the expression of individual tRNA genes in
multicellular organisms in vivo, given that it is impossible to monitor
the products of individual genes from these multigene families except
under very special circumstances (e.g., specific sequence differences
that allow identification of primary transcripts from different family
members [5, 40]).
Kondo et al. (19, 20) have reported on a promising system
which can assay the expression of individual members of the tRNATrp gene family of C. elegans. Genetic
screens with this organism, used to characterize second-site
suppressors of amber mutations, resulted in the isolation and
identification of eight amber-suppressing tRNA gene mutations, all
members of the tRNATrp gene family. In this case, C. elegans provided a unique model system, as attempts to study
informational suppressors in other higher eukaryotes have met with
limited success (3, 8, 22, 23, 30). Molecular
characterization of the C. elegans tRNATrp gene
family showed that while the tRNA coding sequences are identical, flanking sequences and chromosomal locations are different for different loci. When these different suptRNATrp genes were
tested for the ability to suppress a diverse panel of different
amber-mutated genes, suppression was not uniform; i.e., there appeared
to be differential expression of different suptRNATrp
genes. These differences could have been at the level of transcription or of posttranscriptional processing. In addition, a hierarchy of
suppression effectiveness was observed: sup-7 and
sup-5 strongly suppressed all genes tested; some family
members, such as sup-24 and sup-28, suppressed
only a subset (with sup-24 being a stronger suppressor than
sup-28); and the weakest, sup-29, suppressed only the tra-3 mutation (see Table 5 in reference
20). This could be explained if suppressor levels
varied among strains and if each strain had a characteristic level
throughout the animal. However, Kondo et al. also showed that relative
suppression efficiencies among suppressors could change quite
dramatically, depending upon the amber mutation tested. For example,
sup-5/+ animals effectively suppressed several
unc mutations that were not suppressed by
sup-28/sup-28 animals, but sup-5/+ animals failed
to suppress an unc-52 mutation that was suppressed by
sup-28/sup-28 animals. Such data are inconsistent with any
model invoking a constant hierarchy of expression levels. In contrast,
these kinds of differences might be obvious if a suppressor were not
expressed in the tissues or stages most strongly affected by the
amber-mutated gene. Similarly, the differences in the abilities of
sup-28/sup-28 animals to suppress amber mutations in
unc-15 (paromyosin) and unc-52 (perlecan)
(26) might be explained by tissue- or stage-specific
differences in suppressor expression.
In order to examine this problem further, we undertook the study of the
transcription of these genes in vitro and attempted a more direct assay
of suptRNA gene activity in different cell types using an amber-mutated
lacZ reporter gene driven by a heat shock promoter. Our
results suggest that differential expression is probably at the
transcriptional rather than the posttranscriptional level and that
flanking sequences are important for the expression of
sup-7, sup-24, and sup-29 genes in
vitro and probably in vivo. Finally, our results with an amber-mutated
lacZ reporter gene indicate that a hierarchy of suppression
strength (sup-7 is stronger than sup-24 and
sup-28, which are stronger than sup-29) can be observed directly in vivo, providing a system to further explore the
basis of differential expression of this tRNA gene family.
 |
MATERIALS AND METHODS |
Transcription in vitro.
Cell extracts were prepared from
C. elegans embryos, and the labelled products from 25-µl
reaction mixtures were analyzed on 10% polyacrylamide gels as
previously described (15). These extracts efficiently
transcribe and process tRNA genes, yielding a mature transcript as well
as variable amounts of larger precursor RNA (15, 18).
Products were quantitated by excision of transcript bands and Cerenkov
counting, followed by correction for background counts per minute from
an equivalent-sized blank piece of the same gel. Before proceeding,
transcription was optimized for template and total DNA concentration,
as described by Wilson et al. (44). From this, optimal
concentrations of 0.8 nM template and 0.3 µg of total DNA (template
plus carrier pBluescript vector [pBS]) were determined for subsequent
transcription reactions. For each template, a minimum of three
independent reactions were analyzed, and separate extract preparations
were used to eliminate possible batch-specific effects (none were
observed). There were no significant differences in transcription
between the original wild-type and mutant suptRNA gene templates, so
all studies reported here involved mutant suptRNA genes.
Preparation of deletion mutant clones.
Starting recombinant
plasmid clones of both wild-type and corresponding amber suppressor
tRNA genes for sup-5, sup-7, sup-24, sup-28, and sup-29 were described by Kondo et al.
(19). Deletions of cloned suptRNA genes were prepared by the
exonuclease III (exoIII)-S1 strategy of Henikoff (14). For
sup-7 DNA, deletions were made from the 5' end of a 1.0-kb
XbaI fragment, which contains 250 bp of 5' and 700 bp of 3'
flanking sequence, cloned into pBS. This clone was digested with
KpnI and SalI, followed by treatment with
exoIII-S1 and subsequent steps. An additional endpoint was generated by
cloning a 1.3-kb EcoRI-SalI fragment into pBS;
the SalI site occurs 21 bp upstream of the 5' end of the
mature tRNA. This fragment was also subcloned into pUC18 and pUC19 to
generate clones carrying very different 5' flanking vector sequences.
For sup-7 3' deletions, the 1.0-kb
EcoRI-SalI fragment was further cut with
RsaI, and the 5' 500-bp fragment, which contained now only
200 bp of 3' sequence, was recloned into pBS cut with
XbaI/SmaI. This clone was digested with
KpnI and HindIII prior to exoIII-S1 digestion. For the sup-24 gene, a 0.7-kb
NsiI-EcoRI fragment was blunted and cloned into
pBS cut with SmaI, followed by digestion with
KpnI and HindIII prior to deletions being
made. For the sup-29 gene, a 1.0-kb
NsiI-HindIII fragment was cloned into
SmaI-cut pBS, followed by digestion with KpnI and
BamHI. For sup-29, a NarI site 16 bp
upstream of the 5' end of the mature tRNA was used to subclone an
additional deletion endpoint. All clones were sequenced (33)
with Sequenase (version 2.0; U.S. Biochemical Corp.) to verify the
extent of deletion and to confirm that the rest of the tRNA gene
remained intact.
Nematode stocks.
C. elegans strains, obtained from the
Caenorhabditis Genetics Center (University of Minnesota) and J. Hodgkin, were maintained essentially as described by Brenner
(1). Strains used included sup-7 strain DR497
(maintained at 24°C), sup-24 strains CB4425 and CB4435,
sup-28 strain CB3874, and sup-29 strain CB3737.
Site-directed mutagenesis of a lacZ reporter
gene.
Plasmid pPCZ1 carries an amber-mutated lacZ
reporter gene driven by a C. elegans hsp-16 heat shock
promoter (38), generously provided by E. P. M. Candido. A Trp codon in the lacZ gene was mutated to an
amber via the unique site elimination strategy of Deng and Nickoloff
(4) with a kit and instructions provided by the manufacturer
(Pharmacia). The primer used to produce an amber codon was
complementary to nucleotides 255 to 281, CCGTGCATCTGC(T)AGTTTGAGGGGACG, and that used to remove a
flanking EcoRV site was complementary to nucleotides 1116 to
1138, TCATCAGCAG(A)ATATCCTGCACC (the altered bases are shown
in parentheses). Mutagenesis was confirmed by DNA sequencing of
resulting clones.
Transgenic nematodes.
pPCZ1 carrying a lacZ amber
mutation (pPCZ1am) was coinjected into wild-type C. elegans
(9, 25) along with a plasmid carrying rol-6 DNA
as a behavioral marker (21) to help identify transformed
animals. Animals with a roller phenotype were picked, and the presence
of pPCZ1am was confirmed by PCR on isolated genomic DNA by using the
mutagenic primer described above as well as a primer from the
hsp-16 promoter region (nucleotides 3329 to 3348 [31]). Because the various suppressor lines are not as
robust as the wild-type and do not survive injections well, we
introduced the different sup genes into animals carrying
pPCZ1am DNA by using standard genetic crosses (see references
19 and 20 for a more complete
description). Following these crosses, roller progeny were chosen for
in situ staining for beta-galactosidase activity, as previously
described (10), following a heat shock of 2 h at 33°C
and a 15- to 30-min recovery at room temperature (38). Of
the putative extrachromosomal lacZ(Am) roller lines
established, two strains, BH21 and BH22, with roller transmission
frequencies of 70% and 50%, respectively, showed appreciable staining
in the presence of suppressor tRNA genes; others showed weaker or no staining. There was some variability in staining; some animals showed
staining in fewer cells, possibly because of mosaicism. However, there
was always a subset of animals with a consistent, maximum number of
cells stained for each sup type, and these were chosen for
further analysis.
To rule out mosaicism through loss of extrachromosomal pPCZ1am arrays
as a possible factor in any differential staining, animals carrying
integrated copies of pPCZ1am were also generated. BH21 animals were
treated with radiation, followed by selection of roller animals and
multiple backcrosses to remove background mutations. Integrated lines
BH31 and BH34 gave results consistent with those obtained from BH21 and
BH22 but showed much lower levels of lacZ staining. For this
reason, data from BH21 and BH22 are shown in the results.
 |
RESULTS |
Individual suptRNATrp genes are transcribed with
different efficiencies in vitro.
Kondo et al. presented genetic
evidence that individual suptRNATrp genes displayed a
hierarchy of suppression efficiencies for different amber mutations in
C. elegans (19, 20). The tRNAs encoded by the different
family members are identical, suggesting that differences in level
and/or tissue specificity of expression are responsible. We chose five
suptRNA genes for further study, representing a wide range of genetic
suppression in vivo, with sup-5 and sup-7 as
strong, sup-24 as a moderate, and sup-28 and
sup-29 as weak suppressors. Levels of transcription of these
templates in embryonic extracts (Fig. 1)
correlated well with the differential genetic suppression observed by
Kondo et al. (20) and provided evidence for transcriptional
regulation. Levels of transcription in suptRNA genes and their
wild-type counterparts (data not shown) were identical, suggesting that
any observations of suptRNA gene expression in vivo also reflected
expression of the corresponding wild-type tRNATrp genes.
The products of in vitro transcription of these genes yielded the
same-sized wide bands (resolvable into precursor and product on longer
gels [data not shown]) for all of these genes; this suggests that the
primary transcripts of these genes are similar or identical and not
much larger than the mature tRNAs. Much larger differences are
observable in the tRNAMet gene family in this organism
(18). Primer extension experiments (6) confirmed
that transcription initiates at the first purine 2 bp upstream for all
of these genes; the additional 5' sequence is AT for sup-7
and GT for the others (data not shown). The 3' ends of the genes are
likewise nearly identical: AATNTTTT or AANTTTT, with transcription terminating at the run of T residues. This makes it very unlikely that differences in posttranscriptional processing are responsible for the large differences in suppression observed in vivo and further suggests that levels of transcription might be the critical determinant in the observed differential expression.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 1.
Transcription of different suptRNATrp genes
in vitro. (A) This autoradiograph presents a typical experiment, with
samples electrophoresed until the bromophenol blue marker was only
about halfway down the gel to reduce sample spreading for convenience.
(B) Quantitation of transcript labelling for different suptRNA genes.
The amount of incorporation into bands excised from gels such as those
shown in panel A was quantitated by Cerenkov counting, as indicated in
Materials and Methods.
|
|
5' flanking sequences are required for efficient transcription in
vitro.
Flanking sequences have been identified as important
determinants for tRNA transcription in a number of systems (reviewed in
reference 36); we therefore wanted to determine
whether sequences flanking these suptRNATrp genes could
affect expression and perhaps account for the hierarchy of levels of
expression observed.
As a first step, we constructed a series of deletions at the 5' and 3'
ends of the sup-7 gene, the most strongly transcribed in
vitro. We were careful to try to optimize transcription for template
and total DNA concentration to avoid possible saturation of limiting
components and loss of resolution (44). The results of
subsequent transcription assays are given in Fig.
2, an autoradiograph showing
transcription levels, and Fig. 3, a
graphical representation of the results. It appears that sequences
upstream of
21 are strong, positive effectors of transcription; not
unexpectedly, removal of significant portions of internally important
sequences abolishes transcription, while a deletion including the first few nucleotides of the tRNA gives products of other sizes, presumably deriving from start sites in flanking plasmid sequences. To rule out
the possibility that "poisonous" sequences, newly adjacent to the
tRNA gene, inhibited transcription, other sequences (from pUC18 or
pUC19) were also placed 5' to the
21 deletion clone and this resulted
in the same reduced levels of transcription.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 2.
Transcription of sup-7 deletion clones in
vitro. Representative autoradioagraph of transcripts from the indicated
sup-7 deletion derivatives are shown. The top row shows
results for the 5' deletion constructs; the bottom row shows those for
the 3' constructs. Numbers above the lanes identify the endpoints of
the deletion constructs used.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Graphical representation of transcription of
sup-7 deletion clones in vitro. Transcript labelling was
quantitated as for Fig. 2. The line below the graph shows the tRNA,
with 5' and 3' boundaries, A and B box internal promoters, and the TTTT
termination sequence. The extent of DNA remaining after deletions is
shown under the tRNA map.
|
|
At the 3' end of the sup-7 gene, a deletion leaving 3' 35 bp
(+107) was still efficiently transcribed. The tRNA coding region is 72 bp in length, so the next deletion (sup-7, +66) enters the gene and also removes the termination signal. Transcription of this
template resulted in two larger transcripts (approximately 150 nucleotides presumably terminating at runs of T residues in the
flanking plasmid sequence). After correcting for the larger sizes of
these transcripts, it appeared that transcription was significantly
reduced for this clone; however, this may have been due to an
underestimation of total transcription rather than a loss of a putative
positive element if, for example, RNA polymerase III failed to
terminate efficiently.
Similar 5' deletions were performed on sup-24, a gene with
intermediate activity, and sup-29, a weak suppressor, in
order to see the effects of flanking sequences on other
suptRNATrp genes. The results are shown in Fig.
4. We did not observe any strong effects,
e.g., negative regulatory elements; instead, it appears that these
genes lack the stronger promoter characteristic of the sup-7
gene.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Graphical representation of transcription of
sup-24 (A) and sup-29 (B) deletion clones in
vitro. See Fig. 3 and Materials and Methods.
|
|
Differential suppression of a lacZ(Am) reporter gene in vivo in
C. elegans mutants carrying different suptRNA alleles.
We wished to examine further the apparent differential expression of
different suptRNATrp genes, observed directly in vitro and
indirectly via genetic suppression in vivo. If the primary transcripts
were sufficiently different, it might be possible to use these
differences to discriminate among individual genes, e.g., to use
gene-specific oligonucleotides for in situ hybridization. However, as
noted above, the primary transcripts for these sup genes are
too similar. Fortunately, the availability of viable suptRNA mutants
allowed us to look at the biological activity of individual gene family
members via their amber suppressor activity. To take advantage of this,
we constructed transgenic nematode lines which carry an amber-mutated lacZ reporter gene driven by an hsp-16 heat shock
promoter and derived from the wild-type hsp lacZ vector
pPCZ1 (38). Expression of lacZ in transgenic
animals carrying wild-type pPCZ1 is nearly ubiquitous, with blue color
in almost all cell types (with the exception of germ line and early
embryo cells [38]).
As shown in Fig. 5, when suptRNA genes
were introduced into lacZ(Am)-containing BH21 animals,
staining for beta-galactosidase activity also paralleled the results of
transcription in vitro and amber suppression in vivo; the most cell
staining was observed with sup-7/+ (almost comparable to
staining with the wild-type lacZ gene of pPCZ1), followed by
sup-24/+ and sup-28/+, followed by
sup-29/+. A similar hierarchy was observed in earlier
developmental stages, although cell staining was less consistent and
the cells were very difficult to identify (data not shown). It is
interesting to note that sup-28 appeared to stain at least
as well as sup-24/+, and we observed clear differences
in cell staining between these two genotypes. sup-24/+
animals consistently showed staining of cells around the pharynx (Fig.
6); this staining was absent in sup-28/+ animals. On the other hand, it is clear from Fig. 5
that sup-28/+ animals showed staining of posterior cells not
observed in sup-24/+ animals. Homozygote
sup-29/sup-29 animals showed more cells being stained than
sup-29/+ heterozygotes, which is also consistent with the
genetic data reported by Kondo et al. (20).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
Staining of beta-galactosidase activity from
lacZ(Am) genes in suppressor-containing strains. suptRNA
genes were introduced into lacZ(Am)-containing animals as
described. Animals were heat shocked, stained for beta-galactosidase
activity, and photographed. Representatives from those animals with the
maximum numbers of cells stained are shown; because each cross
generates both males and females, in some cases the animals shown are
males (e.g., 24/+, upper animal; 29/+, both animals).
|
|

View larger version (120K):
[in this window]
[in a new window]
|
FIG. 6.
Staining of beta-galactosidase activity from
lacZ(Am) genes in the head regions of three
sup-24/+ animals. See the legend to Fig. 5 and Materials and
Methods for details.
|
|
Because the same extrachromosomal lacZ(Am) array was
introduced genetically and then expressed in the different suppressor strains, we were able to rule out lacZ(Am) copy number
variation as a source of the differences in expression. The
lacZ(Am) gene is present in extrachromosomal arrays which
can be variably retained, so mosaicism might be considered a problem.
However, the same hierarchy of staining was also observed in a second
independently derived extrachromosomal line, BH22, as well as with two
nematode strains, BH31 and BH34, carrying chromosomally integrated
lacZ(Am) genes (data not shown).
 |
DISCUSSION |
We observed that the levels of transcription of
suptRNATrp genes in vitro were consistent with the
hierarchy of genetic suppression levels observed in vivo by Kondo et
al. This close correspondence and the similarity or identity of primary
transcripts for the various suptRNA genes suggest that differential
expression of individual tRNATrp gene family members is
likely at the transcriptional rather than the posttranscriptional
level. It should be noted, however, that the extracts used were
embryonic. It has not been possible to prepare active extracts from
individual tissues or developmental stages; we may therefore have
missed other tissue- or developmental stage-specific effects. The
levels of transcription of suppressor and corresponding wild-type tRNA
genes were identical, which is not surprising, as the single base
change in the anticodon loop should not have strongly influenced any
critical internal promoter sequences. This suggests that any
observations of suptRNA expression in vivo should accurately reflect
the behavior of the corresponding wild-type genes.
The results also indicate the presence of putative positive regulatory
elements upstream of the sup-7 gene, elements not present 5'
to the sup-24 and sup-29 genes. We believe it
extremely unlikely that poisonous vector flanking sequences were
responsible for the low levels of transcription seen in the more
proximal sup-7, sup-24, and sup-29
deletions because (i) the same low level of transcription is seen when
two other sets of flanking sequences are placed in front of
sup-7(-21) and (ii) vector replacement of the same proximal
5' region (upstream of
2) in sup-24 and sup-29
has completely different effects, i.e., transcription of sup-24(-3) is low, while that of sup-29(-2) is
near wild-type levels.
We conclude that flanking sequences appear to play an important role in
determining the levels of differential expression of
tRNATrp genes in vitro, and possibly in vivo as well. Some
transgenic C. elegans strains, which were engineered to
integrate various class II gene constructs into the genome, also carry
a sup-7 gene with vector sequences adjacent to position
21
(24). It is interesting that this type of sup-7
deletion, which reduces transcription in vitro, can also decrease
genetic suppression in vivo by the sup-7 gene
(20). In addition, strains carrying the sup-7
gene with complete 5' flanks are unhealthy, presumably reflecting
problems resulting from carrying strongly expressed suptRNA
(42); these strains with deleted sup-7 5' flanks
are more robust and fertile, which is also consistent with weaker
suptRNA expression in these animals. Our preliminary results with three
of these transgenic lines indicate that staining in hsp
lacZ(Am) animals is also reduced, further implying that loss of
these flanking sequences reduces sup-7 expression in vivo
(data not shown). This is all consistent with the hypothesis that these
flanking sequences are critical to efficient transcription in vivo.
However, because these constructs have different chromosomal locations
and differences in accompanying class II gene sequences, we cannot rule
out possible local chromosome position or other effects. To do so
requires generating and more carefully examining a larger sample size
and standardizing the position and sequence of accompanying class II
transcription units which might interfere with tRNA expression, or vice
versa. Clear effects of flanking sequences on tRNA expression in vivo
have been observed in yeast (28), as have examples of strong
position effects (34) and effects of tRNA genes on class II
gene expression (17).
Our more direct observations of which cell types show
suptRNATrp activity, using an hsp-16-driven
lacZ(Am) reporter gene, are consistent with the genetic
suppression data and again strongly suggest that different
suptRNATrp genes are differentially expressed in vivo. Is
there evidence of tissue specificity in our lacZ(Am)
staining results? We observed that cells around the pharynx were
stained in sup-24/+ but not sup-28/+ animals
(Fig. 6). Some of these cells appeared to be part of the nerve ring, so
this difference in staining would be consistent with the better
suppression, by sup-24, of genes expressed in the nervous
system (20). However, higher overall levels of suptRNA
expression in these sup-24/+ animals (e.g., above some threshold in nerve cells) might also explain this result. Most of the
staining can indeed be accounted for by this simpler model. However,
one clear exception was the observed staining of posterior cells in
sup-28/+ animals, staining which was absent in
sup-24/+ animals. At least some of these cells appeared to
be hypodermal, a result consistent with genetic suppression results
(20) which appeared to show that sup-28 was more
efficient at suppressing presumptive hypodermally acting genes than
those in the nervous system.
Our results support the idea that there is some tissue specificity in
suptRNA gene expression; however, some caution is necessary, as it can
be difficult to precisely identify specific cells in the stained
animals because of their twisted roller phenotype. We were careful to
choose animals with a consistent maximum number of cells stained,
thereby excluding any which were not optimally stained, due either to
mosaicism or to minor variations in staining observed with
hsp-16 promoter-driven genes (38). Differences in
lacZ(Am) expression resulting from strain-specific mosaicism are unlikely, as we saw similar effects on suptRNA expression in two
independent extrachromosomal transgenic lines as well as in two lines
with integrated lacZ(Am) rol-6 DNA. However, it
is formally possible that strain-specific differences between, for example, a strong versus weak suppressor strain might have other, indirect effects on gene expression, which might account for some of
the differences observed.
Our results suggest that it should now be possible to express
lacZ(Am) or another reporter gene under the control of
other, more specific promoters whose tissue and developmental
expression patterns have been well characterized. It should also be
possible to generate integrated transgenic C. elegans
strains carrying suptRNA genes with different flanking sequences and/or
accompanying transcription units to study how expression is affected in
vivo; such constructs might also provide tools for examination of local chromatin structure (7). The results should provide new
insights into the regulation and differential expression of individual tRNA genes in multicellular organisms.
 |
ACKNOWLEDGMENTS |
We thank D. Baillie and members of his lab, especially D. Janke
and J. Schein, for help and expertise; E. Stringham and P. Candido for
pPZ1; A. Fire, E. Hedgecock, D. Moerman, Don Jones, and our research
colleagues in the lab for advice and assistance; two anonymous
reviewers for helpful comments; and J. Hodgkin and R. Waterston for
continued support. We also thank J. Hodgkin, M. MacMorris, and the
Caenorhabditis Genetics Center, supported by the U.S. NIH Division of
Research Resources, for some strains of C. elegans.
This work was supported by a grant from NSERC Canada to B.M.H.
R. M. Linning held an NSERC Canada postgraduate fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Molecular Biology and Biochemistry and Department of Biological
Sciences, Simon Fraser University, Burnaby, British Columbia V5A 1S6,
Canada. Phone: (604) 291-4804. Fax: (604) 291-5583. E-mail:
honda{at}sfu.ca.
 |
REFERENCES |
| 1.
|
Brenner, S.
1974.
The genetics of Caenorhabditis elegans.
Genetics
77:71-94[Abstract/Free Full Text].
|
| 2.
|
Candelas, G. C.,
G. Arroyo,
C. Carrasco, and R. Dompensciel.
1990.
Spider silkglands contain a tissue-specific alanine tRNA that accumulates in vitro in response to the stimulus for silk protein synthesis.
Dev. Biol.
140:215-220[Medline].
|
| 3.
|
Capone, J. P.,
P. A. Sharp, and U. L. RajBhandary.
1985.
Amber, ochre and opal suppressor tRNA genes derived from a human serine tRNA gene.
EMBO J.
4:213-221[Medline].
|
| 4.
|
Deng, W. P., and J. A. Nickoloff.
1992.
Site-directed mutagenesis of virtually any plasmid by eliminating a unique site.
Anal. Biochem.
200:81-88[Medline].
|
| 5.
|
Dingermann, T.,
E. Amon-Bohm,
W. Bertling,
R. Marschalek, and K. Nerke.
1988.
A family of non-allelic tRNAGUUVal genes from the cellular slime mold Dictyostelium discoideum.
Gene
73:373-384[Medline].
|
| 6.
|
Dingermann, T., and K. Nerke.
1987.
Primer extension analysis of tRNA gene transcripts synthesized in vitro and in vivo.
Anal. Biochem.
162:466-475[Medline].
|
| 7.
|
Dixon, D. K.,
D. Jones, and E. P. M. Candido.
1990.
The differentially expressed 16kD heat shock genes of Caenorhabditis elegans exhibit differential changes in chromatin structure during heat shock.
DNA Cell Biol.
9:177-191[Medline].
|
| 8.
|
Doerig, R. E.,
B. Suter,
M. Gray, and E. Kubli.
1988.
Identification of an amber nonsense mutation in the rosy 516 gene by germline transformation of an amber suppressor tRNA gene.
EMBO J.
7:2579-2584[Medline].
|
| 9.
|
Fire, A.
1986.
Integrative transformation of Caenorhabditis elegans.
EMBO J.
5:2673-2680[Medline].
|
| 10.
|
Fire, A.,
S. White Harrison, and D. Dixon.
1990.
A modular set of beta-galactosidase fusion vectors for studying gene expression in Caenorhabditis elegans.
Gene
93:189-198[Medline].
|
| 11.
|
Fournier, A.,
R. Taneja,
R. Gopalkrishnan,
J.-C. Prudhomme, and K. P. Gopinathan.
1993.
Differential transcription of multiple copies of a silk worm gene encoding tRNAGly1.
Gene
134:183-190[Medline].
|
| 12.
|
Geiduschek, E. P., and G. P. Tocchini-Valentini.
1988.
Transcription by RNA polymerase III.
Annu. Rev. Biochem.
57:873-904[Medline].
|
| 13.
|
Hatfield, D.
1985.
Suppression of termination codons in higher eukaryotes.
Trends Biochem. Sci.
10:201-204.
|
| 14.
|
Henikoff, S.
1984.
Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.
Gene
28:351-359[Medline].
|
| 15.
|
Honda, B. M.,
R. H. Devlin,
D. W. Nelson, and M. Khosla.
1986.
Transcription of class III genes in cell-free extracts from the nematode Caenorhabditis elegans.
Nucleic Acids Res.
14:869-881[Abstract/Free Full Text].
|
| 16.
|
Huet, J.,
N. Manard,
G. Dieci,
G. Peyroche,
C. Conesa,
O. Lefebvre,
A. Ruet,
M. Riva, and A. Sentenac.
1996.
RNA polymerase III and class III transcription factors from Saccharomyces cerevisiae.
Methods Enzymol.
273:249-267[Medline].
|
| 17.
|
Hull, M. W.,
J. Erickson,
M. Johnston, and D. R. Engelke.
1994.
tRNA genes as transcriptional repressor elements.
Mol. Cell. Biol.
14:1266-1277[Abstract/Free Full Text].
|
| 18.
|
Khosla, M. K., and B. M. Honda.
1989.
Initiator tRNAMet genes from the nematode Caenorhabditis elegans.
Gene
76:321-330[Medline].
|
| 19.
|
Kondo, K.,
J. Hodgkin, and R. H. Waterston.
1988.
Differential expression of five tRNAUAGTrp amber suppressors in Caenorhabditis elegans.
Mol. Cell. Biol.
8:3627-3635[Abstract/Free Full Text].
|
| 20.
|
Kondo, K.,
B. Makovec,
R. H. Waterston, and J. Hodgkin.
1990.
Genetic and molecular analysis of eight tRNAtrp amber suppressors in Caenorhabdiditis elegans.
J. Mol. Biol.
215:7-19[Medline].
|
| 21.
|
Kramer, J. M.,
R. P. French,
E.-C. Park, and J. J. Johnson.
1990.
The Caenorhabditis elegans rol-6 gene, which interacts with the sqt-1 collagen gene to determine organismal morphology, encodes a collagen.
Mol. Cell. Biol.
10:2081-2089[Abstract/Free Full Text].
|
| 22.
|
Kuchino, Y., and T. Muramatsu.
1996.
Nonsense suppression in mammalian cells.
Biochimie
78:1007-1015[Medline].
|
| 23.
|
Laski, F. A.,
S. Ganguly,
P. A. Sharp,
U. L. RajBhandary, and G. M. Rubin.
1989.
Construction, stable transformation and function of an amber suppressor tRNA gene in Drosophila melanogaster.
Proc. Natl. Acad. Sci. USA
86:6696-6698[Abstract/Free Full Text].
|
| 24.
|
MacMorris, M.,
S. Broverman,
S. Greenspoon,
K. Lea,
C. Madej,
T. Blumenthal, and J. Spieth.
1992.
Regulation of vitellogenin gene expression in transgenic Caenorhabditis elegans: short sequences required for activation of the vit-2 promoter.
Mol. Cell. Biol.
12:1652-1662[Abstract/Free Full Text].
|
| 25.
|
Mello, C. C.,
J. M. Kramer,
D. Stinchcomb, and V. Ambros.
1991.
Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences.
EMBO J.
10:3959-3970[Medline].
|
| 26.
|
Moerman, D. G.,
H. Hutter,
G. P. Mullen, and R. Schnabel.
1996.
Cell autonomous expression of perlecan and plasticity of cell shape in embryonic muscle of C. elegans.
Dev. Biol.
173:228-242[Medline].
|
| 27.
|
Palmer, J. M., and W. R. Folk.
1990.
Unraveling the complexities of transcription by RNA polymerase III.
Trends Biochem. Sci.
15:300-304[Medline].
|
| 28.
|
Raymond, K. C.,
G. J. Raymond, and J. D. Johnson.
1985.
In vivo modulation of yeast tRNA gene expression by 5'-flanking sequences.
EMBO J.
4:2649-2656[Medline].
|
| 29.
|
Reynolds, W. F.
1995.
Developmental stage-specific regulation of Xenopus tRNA genes by an upstream promoter element.
J. Biol. Chem.
270:10703-10710[Abstract/Free Full Text].
|
| 30.
|
Robinson, D. N., and L. Cooley.
1997.
Examination of the function of two kelch proteins generated by stop codon supression.
Development
124:1405-1417[Abstract].
|
| 31.
|
Russnak, R. H., and E. P. M. Candido.
1985.
Locus encoding a family of small heat shock genes in Caenorhabditis elegans: two genes duplicated to form a 3.8-kilobase inverted repeat.
Mol. Cell. Biol.
5:1268-1278[Abstract/Free Full Text].
|
| 32.
|
Sajjadi, F. G., and G. B. Spiegelman.
1987.
Modulation of a Drosophila melanogaster tRNA gene transcription in vitro by a sequence TNNCT in its 5' flank.
Gene
60:13-19[Medline].
|
| 33.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 34.
|
Schnell, R., and J. Rine.
1986.
A position effect on the expression of a tRNA gene mediated by the SIR genes in Saccharomyces cerevisiae.
Mol. Cell. Biol.
6:494-501[Abstract/Free Full Text].
|
| 35.
|
Sharp, S. J.,
J. Schaak,
L. Cooley,
D. J. Burke, and D. Soll.
1985.
Structure and transcription of eukaryotic tRNA genes.
Crit. Rev. Biochem.
19:107-144[Medline].
|
| 36.
|
Sprague, K. U.
1995.
Transcription of eukaryotic tRNA genes, p. 31-50. In
D. Söll, and U. L. RajBhandary (ed.), tRNA: structure, biosynthesis, and function.
American Society for Microbiology, Washington, D.C.
|
| 37.
|
Sprague, K. U.,
O. Hagenbuchle, and M. C. Zuniga.
1977.
The nucleotide sequence of two silkgland alanine tRNAs: implications for fibroin synthesis and for initiator tRNA structure.
Cell
22:171-178.
|
| 38.
|
Stringham, E. G.,
D. K. Dixon,
D. K. Jones, and E. P. M. Candido.
1992.
Temporal and spatial expression patterns of the small heat shock (hsp16) genes in transgenic Caenorhabditis elegans.
Mol. Biol. Cell
3:221-233[Abstract].
|
| 39.
|
Stutz, F.,
E. Gouilloud, and S. G. Clarkson.
1989.
Oocyte and somatic tyrosine tRNA genes in Xenopus laevis.
Genes Dev.
3:1190-1198[Abstract/Free Full Text].
|
| 40.
|
Suter, B., and E. Kubli.
1988.
tRNATyr genes of Drosophila melanogaster: expression of single-copy genes studied by S1 mapping.
Mol. Cell. Biol.
8:3322-3331[Abstract/Free Full Text].
|
| 41.
|
Wang, H.-D.,
C.-H. Yuh,
C. V. Dang, and D. L. Johnson.
1995.
The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes.
Mol. Cell. Biol.
15:6720-6728[Abstract].
|
| 42.
|
Waterston, R. H.
1981.
A second informational suppressor, sup-7, in Caenorhabditis elegans.
Genetics
97:307-325[Abstract/Free Full Text].
|
| 43.
|
Willis, I. M.
1993.
RNA polymerase III. Genes, factors and transcriptional specificity.
Eur. J. Biochem.
212:1-11[Medline].
|
| 44.
|
Wilson, E. T.,
D. Larson,
L. S. Young, and K. U. Sprague.
1985.
A large region controls tRNA gene transcription.
J. Mol. Biol.
183:153-163[Medline].
|
| 45.
|
Wolffe, A. P.
1991.
RNA polymerase III transcription.
Curr. Opin. Cell Biol.
3:461-466[Medline].
|
| 46.
|
Young, L. S.,
N. Ahnert, and K. U. Sprague.
1996.
Silkworm TFIIIB binds both constitutive and silk gland-specific tRNAAla promoters but protects only the constitutive promoter from DNase I cleavage.
Mol. Cell. Biol.
16:1256-1266[Abstract].
|
| 47.
|
Young, L. S.,
N. Takahashi, and K. U. Sprague.
1986.
Upstream sequences confer distinctive transcriptional properties on genes encoding silkgland-specific tRNAAla.
Proc. Natl. Acad. Sci. USA
83:374-378[Abstract/Free Full Text].
|
Mol Cell Biol, February 1998, p. 703-709, Vol. 18, No. 2
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Branicky, R., Nguyen, P. A. T., Hekimi, S.
(2006). Uncoupling the Pleiotropic Phenotypes of clk-1 with tRNA Missense Suppressors in Caenorhabditis elegans. Mol. Cell. Biol.
26: 3976-3985
[Abstract]
[Full Text]
-
Martin, M. P., Gerlach, V. L., Brow, D. A.
(2001). A Novel Upstream RNA Polymerase III Promoter Element Becomes Essential When the Chromatin Structure of the Yeast U6 RNA Gene Is Altered. Mol. Cell. Biol.
21: 6429-6439
[Abstract]
[Full Text]